AACR 101st Annual Meeting 2010: Special Sessions and Lectures

Cancer and Biomedical Research Career Fair

9:00 a.m.-3:00 p.m.

Thirteenth Annual AACR-Women in Cancer Research Charlotte Friend Memorial Lecture

5:30 p.m.-6:30 p.m.

• Skin stem cells in morphogenesis and cancer
  Elaine V. Fuchs, Howard Hughes Medical Institute, New York, NY

Sixth Annual AACR-Irving Weinstein Foundation Distinguished Lecture

5:30 p.m.-6:30 p.m.

• Transcription factors and cancer: An uneasy partnership
  Robert Tjian, University of California, Berkeley, CA

AACR-Love/Avon Army of Women Panel Discussion
New Opportunities in Translational Research: Innovation Through Collaboration Between Women and Scientists

5:30 p.m.-6:30 p.m.

Panelists:
• Susan Love, Dr. Susan Love Research Foundation, Santa Monica, CA
• Thea Tlsty, University of California, San Francisco, CA
• Leslie Bernstein, City of Hope Cancer Center, Duarte, CA
• Elizabeth Claus, Yale University, New Haven, CT
• Seema Khan, Northwestern University, Chicago, IL

101st Annual Meeting Opening Ceremony

8:15 a.m.-9:30 a.m.

Special Symposium
Future Leaders in Translational Research

1:00 p.m.-3:30 p.m.
Sponsored by the Associate Member Council

Speakers:
• Florian Karreth, Cambridge Research Institute, Cambridge, United Kingdom
• Jialiang Wang, Duke University, Durham, NC
• Emma Ito, University of Toronto Ontario Cancer Institute, Toronto, ON, Canada
• Peter H. O'Donnell, University of Chicago, Chicago, IL
• Matthias Stephan, Massachusetts Institute of Technology, Cambridge, MA

Special Session
New Drugs on the Horizon

3:15 p.m.-5:15 p.m.
Co-Chairpersons: Matthew A. Marx, Pfizer, Inc., San Diego, CA, and Lori S. Friedman, Genentech, Inc., South San Francisco, CA

• NMS-1116354: More than an inhibitor Cdc7 kinase in S phase
  Francesco Colotta, Nerviano Medical Sciences, Nerviano, Italy
• Targeting EGFR and HER3 with a “two-in-one” antibody
  Gabriele M. Schaefer, Genentech, Inc., South San Francisco, CA
• TAK-700: An inhibitor of 17, 20-lyase
  Masero Yamaoka, Takeda Pharmaceuticals Co. Ltd., Osaka, Japan
• NVP-BKM120: A selective inhibitor of type I PI3-kinases
  William R. Sellers, Novartis Institutes for BioMedical Research, Cambridge, MA

Fifth Annual AACR-Minorities in Cancer Research Jane Cooke Wright Lecture

4:15 p.m.-5:30 p.m.

• Lecturer and title to be announced

European Commission-Sponsored Session
Coordination of Translational Cancer Research in Europe

4:30 p.m.-5:30 p.m.
Chairperson: Jan-Willem van de Loo, European Commission, Brussels, Belgium

Presidential Address

5:30 p.m.-6:30 p.m.

• 2010 Vision: Challenges and Opportunities for Cancer Research and Cancer Researchers
  Tyler Jacks, MIT Koch Institute for Integrative Cancer Research, Cambridge, MA

AACR Annual Business Meeting

12:30 p.m.-1:45 p.m.

Special Session
Clinical Cancer Research as an Engine for Improving Patient Care – But at What Cost? Ethical and Financial Aspects

2:30 p.m.-4:30 p.m.
Co-Chairpersons: Lowell E. Schnipper, Beth Israel Deaconess Medical Center, Boston, MA, and Walter Wolf, University of Southern California School of Pharmacy, Los Angeles, CA

• Values in cancer care
  Dan W. Brock, Harvard Medical School, Cambridge, MA
• Cancer chemotherapy and marginal benefits: Are we making too much of too little or are we achieving too little by giving too much?
  Tito Fojo, National Cancer Institute, Bethesda, MD
• Biology-driven clinical decision making: Implications for stakeholders
  David R. Parkinson, Nodality, South San Francisco, CA
• How much can we afford to pay for new drugs, and how do we make those decisions?
  Thomas J. Smith and Bruce E. Hillner, Virginia Commonwealth University, Richmond, VA

Fiftieth Annual AACR G.H.A. Clowes Memorial Award Lecture

3:30 p.m.-4:30 p.m.

• How telomeres solve the end-protection problem and its relevance to cancer
  Titia de Lange, Rockefeller University, New York, NY

Fourth Annual AACR Princess Takamatsu Memorial Lecture

3:30 p.m.-4:30 p.m.

• Title to be announced
  Mary-Claire King, University of Washington, Seattle, WA

Thirteenth Annual Pezcoller Foundation-AACR International Award for Cancer Research

5:00 p.m.-6:00 p.m.

• Cell signaling by receptor tyrosine kinases: From basic principles to cancer therapy
  Joseph Schlessinger, Yale University School of Medicine, New Haven, CT

Science Policy Forum
Cancer Policy and Funding: How Do We Avoid Falling Off the Funding Cliff?

5:00 p.m.-6:00 p.m.
Moderator: William Dalton, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Science Policy Forum
Healthcare Reform: The Confluence of Comparative Effectiveness, Health IT, and Personalized Medicine

10:30 a.m.-12:30 p.m.
Moderator: Gilbert Omenn, University of Michigan, Ann Arbor MI

Nineteenth Annual AACR-American Cancer Society Award Lecture for Research Excellence in Cancer Epidemiology and Prevention

3:00 p.m.-4:00 p.m.

• Title to be announced
  Michael J. Thun, American Cancer Society, Atlanta, GA

Thirtieth Annual AACR Award for Outstanding Achievement in Cancer Research Lecture

3:00 p.m.-4:00 p.m.

• Title to be announced
  Joshua T. Mendell, Johns Hopkins University School of Medicine, Baltimore, MD

Fourth Annual AACR Award for Outstanding Achievement in Chemistry in Cancer Research Lecture

3:00 p.m.-4:00 p.m.

• Small-molecule probes of cancer biology
  Stuart L. Schreiber, Harvard University, Boston, MA

Science Policy Forum
Integrating Science and Policy to Combat the Global Tobacco Epidemic

3:00 p.m.-4:30 p.m.
Moderators: Ellen R. Gritz, UT M. D. Anderson Cancer Center, Houston, TX, and Roy S. Herbst, UT M. D. Anderson Cancer Center, Houston, TX

Fifteenth Annual AACR Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research Lecture

4:00 p.m.-5:00 p.m.

• Title to be announced
  Henry T. Lynch, Creighton University School of Medicine, Omaha, NE

Joint AACR/ASCO Forum
Drug Development in the 21st Century

5:00 p.m.-6:30 p.m.
Co-Chairpersons: Tyler Jacks, MIT Koch Institute for Integrative Cancer Research, Cambridge, MA, and Douglas W. Blayney, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI

• Speakers to be announced

Thirty-fourth Annual AACR Richard and Hinda Rosenthal Memorial Award Lecture

10:00 a.m.-11:00 a.m.

• Title to be announced
  Pasi Jänne, Dana-Farber Cancer Institute, Boston, MA